Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT03121300
Official study title

Functional Imaging in Lung SBRT

Study summary

Little is known about the safety of body radiation therapy (SBRT), especially the impact on pulmonary function, quality of life, and on functional changes within the lung itself. Radiation dose constraints and capturing functional changes on imaging are not well studied in this setting. The current study aims to evaluate the utility of advanced imaging to measure lung function prior to and after treatment and to assess the feasibility of using this data to adapt SBRT planning.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedCT Scan and Lung CT

Plus 6 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 17, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Michigan Rogel Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Michigan Rogel Cancer Center
Interventions being studied
Other: CT Scan; Other: Lung CT; Other: MRI; Other: Walk Test; Other: SGRQ; Other: Biological Sample Collection; Other: Toxicity; Other: Cardiac Assessment
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Radiation therapy→
Study topics
Survivorship and quality of life→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patients receiving SBRT lung treatment and who have any one of the following high risk features:
  • Lung lesion \> 5 cm
  • DLCO \< 35%
  • FEV1 \< 0.5 L
  • Central lung tumors (defined as within 2 cm from the proximal bronchial tree)
  • Tumors that abut the great vessels, trachea, spinal cord, or esophagus
  • Prior lobectomy or pneumonectomy
  • Prior lung radiation (SBRT or conventional definitive lung radiation)
  • Patients must be 18 years of age or older
Reasons someone may not be able to joinExclusion criteria
  • Patients who have received targeted agents or systemic potentially radiosensitizing chemotherapy within 2 weeks of lung SBRT start
  • Pregnancy or lactation
  • Unable to tolerate MRI without anesthesia
  • Inability cooperate with the scans

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of MichiganAnn Arbor, Michigan

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 17, 2019. Always confirm current availability with the study team.

View original record ↗